Prognosis

CureVac’s Shot Could Arrive Just in Time

Here’s the latest news from the global pandemic.

It was rough last week on the Covid vaccine front, with the U.S. government suspending use of Johnson & Johnson’s shot out of fears that it can cause a rare form of sometimes-fatal blood clotting. Those concerns had already hobbled a vaccine made with similar technology by AstraZeneca, which some countries have avoided using.